Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enact Holdings (ACT) Other Accumulated Expenses (2020 - 2025)

Historic Other Accumulated Expenses for Enact Holdings (ACT) over the last 6 years, with Q3 2025 value amounting to $572.1 million.

  • Enact Holdings' Other Accumulated Expenses rose 1207.93% to $572.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $572.1 million, marking a year-over-year increase of 1207.93%. This contributed to the annual value of $524.7 million for FY2024, which is 125.9% up from last year.
  • According to the latest figures from Q3 2025, Enact Holdings' Other Accumulated Expenses is $572.1 million, which was up 1207.93% from $551.9 million recorded in Q2 2025.
  • Enact Holdings' 5-year Other Accumulated Expenses high stood at $648.4 million for Q3 2021, and its period low was $490.2 million during Q2 2023.
  • Over the past 5 years, Enact Holdings' median Other Accumulated Expenses value was $524.7 million (recorded in 2024), while the average stood at $544.4 million.
  • Per our database at Business Quant, Enact Holdings' Other Accumulated Expenses soared by 1541.29% in 2021 and then crashed by 2130.4% in 2022.
  • Quarter analysis of 5 years shows Enact Holdings' Other Accumulated Expenses stood at $641.3 million in 2021, then fell by 19.07% to $519.0 million in 2022, then fell by 0.16% to $518.2 million in 2023, then rose by 1.26% to $524.7 million in 2024, then rose by 9.02% to $572.1 million in 2025.
  • Its Other Accumulated Expenses was $572.1 million in Q3 2025, compared to $551.9 million in Q2 2025 and $542.5 million in Q1 2025.